NAS:MRTX (USA) Also Trade In: Germany
Mirati Therapeutics Inc $ 161.09 -0.88 (-0.54%)
Warning! GuruFocus has detected 2 Severe warning signs with MRTX. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for MRTX (Mirati Therapeutics Inc) from 2013 to Sep 21 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Mirati Therapeutics stock (MRTX) PE ratio as of Sep 21 2020 is 0. More Details
Mirati Therapeutics PE Ratio (TTM) Historical Data
View and export this data going back to 2013. Start your Free Trial
Mirati Therapeutics PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:RARE NAS:FTSV NAS:CRSP NAS:BBIO NAS:GBT NAS:CBPO NAS:ZLAB NAS:NKTR NAS:VIR NAS:MYOK OCSE:NOVO B ASX:CSL NAS:VRTX NAS:REGN XKRX:207940 NAS:SGEN NAS:MRNA NAS:ALXN XKRX:068270 NAS:INCY
Address 9393 Towne Centre Drive, Suite 200, San Diego, CA, USA, 92121
Mirati Therapeutics is an American biotechnology company. The company's medical focus is precision medicine: genetically targeted oncology therapeutics for selected patients. Mirati's drug candidates target specific genetic and epigenetic drivers of cancer.